CRISPR Therapeutics AG (CRSP) |
|
33.08 -4.05 (-10.91%)
|
01-22 16:00 |
|
Open: |
33.96 |
Pre. Close: |
37.13 |
|
High:
|
33.99 |
Low:
|
31.2201 |
|
Volume:
|
2,728,531 |
Market Cap:
|
1714M |
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
34.017 - 34.189 |
34.189 - 34.299 |
|
Low:
|
30.834 - 31.048 |
31.048 - 31.186 |
|
Close:
|
32.756 - 33.097 |
33.097 - 33.315 |
|
|
|
Technical analysis |
as of: 2019-01-22 4:29:51 PM |
|
Overall:
|
  |
| Stoxline posted a STRONG SELL today, downgraded from higher rating. This stock seems to be very strong for short side. So you may continue to hold the short positions or sell your long positions. It is relatively safe to short or sell, downward move is expected. |
| Target: |
Six months: 43.76 One year: 51.12 |
| Support: |
Support1: 28.05 Support2: 22.22 |
| Resistance: |
Resistance1: 37.47 Resistance2: 43.76 |
| Pivot: |
33.50  |
| Moving Average: |
MA(5): 35.38 MA(20): 31.45
MA(100): 38.28 MA(250): 46.82 |
| MACD: |
MACD(12,26): 0.85 Signal(9): 0.32 |
| Stochastic oscillator: |
%K(14,3): 80.69 %D(3): 85.63 |
| RSI: |
RSI(14): 49.53 |
| 52-week: |
High: 73.90 Low: 22.22 Change(%): -14.7 |
| Average Vol(K): |
3-Month: 86162 10-Days: 94616 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.CRSP has closed above bottom band by 46.3%. Bollinger Bands are 1.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
2019-01-22T09:24:04-05:00
ARNC, UBS among premarket losers
2019-01-22T07:48:56-05:00
Citi cuts CRISPR Therapeutics to Sell, shares down 7% premarket
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
